(Q40460056)

English

Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.

scientific article published on March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

based on heuristic

inferred from title

author name string

John A Wijsman

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gregory A Dekaban

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Michael J Rieder

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

346-351

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Comparisons of oxidative metabolism and reductive capacity in sulfonamide-tolerant and -intolerant patients with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite

1 reference

https://api.crossref.org/works/10.1177%2F0091270004272670

21 January 2018

Identifiers

10.1177/0091270004272670

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40460056&oldid=1585825702"